BackForte Biosciences Overview
Forte Biosciences Inc

Forte Biosciences Target Price

See Forte Biosciences's analyst price targets ($76) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$76.61

Average Target Price

$76.000.8% downside

3 analysts in the last 4 months

High: $77 | Low: $74

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-28BarclaysEtzer Darout$770.5% upsideOpen
2026-07-27Evercore ISI$770.5% upsideOpen
2026-07-21Barclays$743.4% downsideOpen
2025-11-25Evercore ISI$6515.2% downsideOpen

Forte Biosciences (FBRX) FAQ

Forte Biosciences's target price stands at $76. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $76 for FBRX implies 0.8% downside versus today's price ($76.61). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Forte Biosciences's target price evolved across reporting periods, while the comparison chart places FBRX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Forte Biosciences's reading of $76 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.